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Abstract
Growth Differentiation Factor-6 (Gdf6) is a member of the Bone Morphogenetic Protein (BMP) family of secreted signaling
molecules. Previous studies have shown that Gdf6 plays a role in formation of a diverse subset of skeletal joints. In mice, loss
of Gdf6 results in fusion of the coronal suture, the intramembranous joint that separates the frontal and parietal bones.
Although the role of GDFs in the development of cartilaginous limb joints has been studied, limb joints are developmentally
quite distinct from cranial sutures and how Gdf6 controls suture formation has remained unclear. In this study we show that
coronal suture fusion in the Gdf62/2 mouse is due to accelerated differentiation of suture mesenchyme, prior to the onset
of calvarial ossification. Gdf6 is expressed in the mouse frontal bone primordia from embryonic day (E) 10.5 through 12.5. In
the Gdf62/2 embryo, the coronal suture fuses prematurely and concurrently with the initiation of osteogenesis in the
cranial bones. Alkaline phosphatase (ALP) activity and Runx2 expression assays both showed that the suture width is
reduced in Gdf6+/2 embryos and is completely absent in Gdf62/2 embryos by E12.5. ALP activity is also increased in the
suture mesenchyme of Gdf6+/2 embryos compared to wild-type. This suggests Gdf6 delays differentiation of the
mesenchyme occupying the suture, prior to the onset of ossification. Therefore, although BMPs are known to promote bone
formation, Gdf6 plays an inhibitory role to prevent the osteogenic differentiation of the coronal suture mesenchyme.
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Introduction
The mammalian cranial vault is composed of five main flat
bones separated by joints known as the cranial sutures. These
sutures are composed of fibrous connective tissue and act as the
main sites for cranial growth during development. As the cranial
vault expands, bone is deposited at the growing edges of the bone
(the bone fronts), while the suture mesenchyme remains un-
differentiated. Sutures provide flexible joints for passage through
the birth canal, act as shock absorbers, prevent separation of the
cranial bones, and accommodate room for the rapidly growing
brain [1]. With the exception of the metopic suture, human
sutures normally do not fuse until the third or fourth decade of life
[2], when the undifferentiated mesenchyme of the suture space
becomes obliterated by bone.
Craniosynostosis is defined as the premature fusion of one or
more of the cranial sutures and occurs in approximately 1 in 2,500
live births [3]. When a suture fuses prematurely, cranial growth
ceases perpendicular to the fused suture, producing a dysmorphic
skull shape. In turn, when the calvarial vault cannot expand
sufficiently to accommodate the rapidly growing brain, increased
intracranial pressure can occur [4]. Coronal craniosynostosis can
result from several potential mechanisms. For example, a failure to
form the developmental boundary between the neural crest-
derived frontal bone and the paraxial mesoderm-derived parietal
bone can result in impaired suture formation. This failed
mechanism is evident as a mixing of the frontal and parietal cell
populations at sites of suture fusion in utero, as seen in the Twist1
mutant mouse [5]. It is thought that Twist1 functions with Msx2 to
control the localization of ephrin-A2 and ephrin-A4, which are
known to play roles in boundary formation at the frontal/parietal
junction by restricting cell migration [5]. Several additional
mechanisms could also lead to fusion of a cranial suture. These
include changes in proliferation, apoptosis, or the rate of
differentiation in the suture mesenchyme or at the leading edges
of the ossifying bone. For example, gain of function mutations in
Fibroblast growth factor receptors (FGFRs) have been associated with
craniosynostosis in humans. Studies in mice have shown that Fgfr2
is expressed in proliferating osteoprogenitor cells surrounding the
ossifying bones while Fgfr1 is expressed more centrally in osteoid of
the developing frontal and parietal bones. As differentiation
progresses, Fgfr2 is downregulated and Fgfr1 is upregulated,
suggesting that signaling through FGFR2 mainly plays a role in
proliferation, while FGFR1 signaling regulates osteogenic differ-
entiation. The contribution of FGFR3 is less clear though its
expression overlaps with FGFR1 and 22 [6]. However, the
P250R gain-of-function mutation in FGFR3 has been associated
with coronal craniosynostosis, either isolated or as part of
syndromes such as Muenke syndrome [7]. While defects in
boundary formation between lineage compartments (e.g. neural
crest and paraxial mesoderm) can explain some of the etiology of
coronal craniosynostosis, it remains less clear how proposed
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sutures while sparing others.
Growth Differentiation Factors (GDFs) 5, 6, and 7 are members
of the Bone Morphogenetic Protein (BMP) family of secreted
signaling molecules. The GDF subgroup (GDF5/6/7) is highly
conserved in vertebrates and has been shown to play a critical role
in limb joint formation and chondrogenesis [8]. Gdf6 homozygous
knockout mice display multiple joint defects, including fusions of
tarsal and carpal bones, morphological abnormalities in the
malleus, incus, and stapes bones of the middle ear, and hypoplasia
of the thyroid cartilage. In addition to these defects, Gdf6 knockout
mice lack the coronal suture [9]. However, the detailed expression
pattern of Gdf6 in the developing skull and its relationship to the
onset of cranial suture fusion in this mutant has not been shown.
Another GDF family member, Gdf5, is mutated in the brachypodism
mouse and normally stimulates cartilage development, growth,
and maturation [8]. Therefore, Gdf5 can be viewed as promoting
aspects of endochondral bone growth. Gdf5 and Gdf6 share
approximately 80% identity in the mature signaling region [10]
and therefore it is likely the Gdf5 and Gdf6 operate by similar
ligand-receptor interactions. Like Gdf5, Gdf6 (a.k.a. CDMP2) can
promote chondrogenic differentiation in vitro [11]. This makes the
craniosynostosis phenotype in the Gdf62/2 mouse particularly
interesting because unlike the long bones, the cranial bones form
through intramembranous ossification without a cartilage in-
termediate. Therefore, the mechanism of Gdf6 function in the
coronal suture may be drastically different than its function in
joints of the axial skeleton.
The aim of this study was to gain a more thorough
developmental understanding of craniosynostosis in the Gdf62/
2 mouse and the underlying cause of suture fusion. We found that
the coronal suture is obliterated in Gdf62/2 embryos before the
first evidence of cranial bone ossification is detectable at E14.5,
with changes in early osteogenic markers detected prior to the
onset of ossification. Our data suggests that Gdf6 may self-regulate
its expression in the developing frontal bone primordium.
Additionally, fusion in the Gdf62/2 is not due to a failure to
form the boundary properly between the frontal and parietal
bones, or changes in cell survival or proliferation, but is likely due
to a failure of the suture mesenchyme to remain in an
undifferentiated state.
Results
Gdf62/2 Coronal Suture Fuses Early in Development
The entire coronal suture was absent in Gdf62/2 fetal mice
(Fig. 1C, F), with complete penetrance (not shown). This defect
was not observed in wild-type (Fig. 1A, D) and Gdf6 heterozygote
littermates (Fig. 1B, E) through embryonic development and
weaning. To determine the time point during development at
which the suture first became fused, Gdf62/2 embryos were
collected at various stages and stained with alizarin red. At E14.0,
ossification centers in either the frontal or parietal bone were not
yet visible by alizarin red staining. By E14.5, frontal and parietal
bones were first visible as two separate ossification centers (Fig. 1G,
J; H, K). The nascent coronal suture was apparent in the wild-type
embryo as the gap between the two bones. Yet in Gdf62/2
embryos, a single continuous ossification center was present
(Fig. 1I, L). Analysis of multiple Gdf62/2 embryos at E13.5–14.5
failed to identify visibly separate sites of alizarin staining for frontal
and parietal rudiments in any specimens (not shown). At E15.5,
the frontal and parietal bones were fused into one continuous bone
in the Gdf62/2 embryo (Fig. 1O), while the bones remained
separated by the coronal suture in the wild-type and heterozygote
(Fig. 1M, N) embryos. The coronal suture continued to fuse along
its entire length as ossification progresses outward in the Gdf62/2
embryo, whereas the sagittal, lambdoid, and squamosal sutures
(Fig. 1A–F) remained unaffected in Gdf62/2 mice throughout
prenatal development. At the macroscopic level, the ossification
centers and suture in Gdf6+/2 appear to develop identically to
wild-type embryos with regards to the onset of ossification and size
of the bones (not shown). This data suggests that Gdf6 plays a role
in coronal suture formation at or prior to the onset of ossification.
Gdf62/2 has Normal Suture Boundary Formation
Coronal craniosynostosis can result from a failure to form
a proper boundary between cells of the neural crest-derived frontal
bone and the paraxial mesoderm-derived parietal bone. The
formation of this boundary involves the cooperation of Twist1 and
Msx2 to control of the expression domains of ephrin-A2, ephrin-
A4, and EphA4 [5]. Ephrin signaling has been shown to inhibit
cell mixing and provide guidance cues for migrating cell
populations [12]. Failed boundary formation is evident as a mixing
of the two cell lineages within the suture mesenchyme, as in the
Twist1 mutant mouse [5].
To determine whether a similar cell mixing was the cause of the
craniosynostosis in the Gdf62/2 embryos, we visualized the
suture boundary using the Wnt1-Cre and R26R transgenic lines,
which together stably label derivates of the neural crest [13],
including the frontal bone. At E16.5, coronal suture fusion was
evident in whole-mount stained Gdf62/2 embryos (Fig. 2A,B).
Transverse sections showed the presence of ossified bone across
the boundary between the frontal and parietal bones in Gdf62/2
(Fig. 2D, arrow), while the suture remained open and un-
differentiated in wild-type (Fig. 2C, arrow). Also of note was
a general thinning of the bone in this region of the Gdf62/2
(Fig. 2D) along with the loss of the characteristic suture
mesenchyme blastema, seen in wild-type embryos (Fig. 2C, arrow).
In the regions of the frontal bone more distal to the suture, there
was no thinning of the Gdf62/2 bone compared to wild-type (not
shown).
In the Gdf62/2 embryo, ossified tissue disrupted the boundary
between the frontal and parietal domains (as seen in Fig. 2D)
making it difficult to determine if cells have crossed the normal
boundary. Therefore embryos were examined at E14.5, when
portions of the Gdf62/2 calvaria were not yet ossified through the
suture. Coronal sections through the region of the presumptive
coronal suture reveal that although the Gdf62/2 lacked an
identifiable suture, the cellular boundary between the frontal and
parietal bones remained distinct just like the wild-type suture
(Fig. 2E,F). We could find no evidence of cell mixing between
these tissue populations and there were no other obvious
differences between wild-type and Gdf6+/2 embryos with regards
to the suture boundary (not shown). Furthermore, we observed
a surprisingly uniform and continuous surface between the frontal
and parietal bones of Gdf62/2, where the suture should reside.
Gdf62/2 and Gdf6+/2 Present with Pre-ossification
Changes in the Suture
Transverse sections through the E12.5 wild-type suture were
stained for alkaline phosphatase (ALP) activity, an early osteoblast
marker, to highlight the frontal and parietal bone primordia with
the presumptive coronal suture in between (Fig. 3A); ALP was
weaker in the band of cells between the primordia, but was faintly
visible across the suture region (Fig. 3A). In Gdf6+/2 embryos,
ALP activity extended through the presumptive suture region
which was shorter as defined by the distance between the flanking
bone primordia (Fig. 3B), revealing less undifferentiated suture
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mice develop normal sutures, ALP was also increased in the
presumptive suture relative to wild-type. This points to a dosage
effect, where loss of one copy of Gdf6 does increase ALP activity in
the suture, but this slightly increased differentiation does not reach
the threshold required for fusion of the suture. In addition, the
suture gap width was reduced in the Gdf6+/2 compared to wild-
type (Fig. 3B). In E12.5 Gdf62/2 embryos, the frontal primor-
dium was clearly visible, but there was no clear region of
concentrated ALP in the parietal primordium; rather, there was
continuous, moderate ALP staining across the region of the
presumptive suture and extending into the region where the
parietal primordia has concentrated ALP activity in wild-type and
Gdf6+/2 embryos (Fig. 3C).
Differentiation of the suture mesenchyme was also examined by
expression of Runx2, another marker for early bone differentiation.
Like ALP, Runx2 marked the presumptive frontal and parietal
bones, with a gap of undifferentiated mesenchyme in between
(Fig. 3D). Again, the distance between the frontal and parietal
rudiments was reduced in the Gdf6+/2 (Fig. 3E). In the Gdf62/2,
Runx2 was expressed continuously through the suture region at
E12.5 (Fig. 3F). These data suggest the presumptive suture region
Figure 1. Analysis of coronal suture development in wild-type and Gdf62/2 embryos with alizarin red. The coronal suture separated
the frontal and parietal bones in wild-type and heterozygote embryos (A, B), but was lacking in the Gdf62/2 embryos (C). At E14.5, the early coronal
suture was a distinct gap between the frontal and parietal ossification centers (G, H, J, K). The coronal suture appeared fused in Gdf62/2 embryos at
the onset of ossification (I, L). The frontal and parietal bones fused into one continuous bone in the Gdf62/2 at E15.5 (O). The sagittal, lambdoid (D–
F), and squamosal (A–C) sutures remained unfused through weaning in both wild-type and Gdf62/2 animals. fb, frontal bone; pb, parietal bone, cs,
coronal suture; ls, lambdoid suture; sqs, squamosal suture.
doi:10.1371/journal.pone.0036789.g001
Figure 2. Analysis of boundary formation in Gdf62/2 embryos. E16.5 Wnt1Cre+/2; R26R+/2; Gdf6+/+ (A) and Wnt1Cre+/2; R26R+/2; Gdf62/
2 (B) embryos were stained with Xgal to label the frontal bone followed by alizarin red to highlight the parietal bone. Sections through the lacZ/
alzarin red stained embryos show the boundary between the labeled frontal bone and unlabeled parietal bone at the site of the wild-type suture (C,
arrow), with bone continuing through the suture boundary in the Gdf62/2 embryo (D, arrow). E14.5 Wnt1Cre+/2; R26R+/2; Gdf6+/+ (E) and
Wnt1Cre+/2; R26R+/2; Gdf62/2 (F) embryos were stained with Xgal and counterstained with nuclear fast red. In both the wild-type and Gdf62/2
coronal sutures, the boundary was distinct, with no evidence of cell mixing. AR, alizarin red; cs, coronal suture; fb, frontal bone; pb, parietal bone.
doi:10.1371/journal.pone.0036789.g002
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characterized by abnormally high ALP and Runx2 expression.
Interestingly, ALP activity is apparently delayed in the parietal
rudiment of Gdf62/2 embryos although Runx2 expression is not.
Increased ALP activity was confirmed at both caudal (closer to
the eye) and rostral (newly formed) levels of the presumptive
coronal suture at E13.5 and E14.5 (caudal, Fig. 3J–L, P–R and
rostral, Fig. 3G–I, M–O). This suggests an increase in osteogenic
differentiation of the cells in the developing suture of the Gdf6+/2
and Gdf62/2 embryos, and also a dosage effect where Gdf6+/2
has intermediately increased differentiation between wild-type and
Gdf62/2 embryos.
A decrease in both the intensity (Fig. 3C,I) and span (not shown)
of ALP activity in the parietal bone rudiment of Gdf62/2
embryos was noted, suggesting a decrease in the rate of
differentiation in this structure. This was also observed in the
alizarin red staining of E14.5 embryos, with a reduction of the size
of the Gdf62/2 parietal bone ossification center compared to
wild-type and Gdf6+/2 (not shown). This could be a potential
secondary effect of loss of the suture, or a direct effect of the loss of
Gdf6.
Loss of Gdf6 does not Significantly Affect Proliferation in
the Nascent Suture
In principle, suture fusion could result from changes in the
number of cells in the suture or bone fronts proliferating or
undergoing apoptosis, thereby increasing or decreasing the
number of cells in the pre-osteogenic pool. Between E14.0 and
E14.5, the frontal and parietal rudiments in the Gdf62/2 are
clearly fused as shown by alizarin red staining into a single ossified
element (Fig. 1I, L). Therefore the sutures of wild-type, Gdf6+/2,
and Gdf62/2 littermates were examined for changes in pro-
liferation or apoptosis at E12.5, concurrent with the earliest
detectable changes in ALP staining (Fig. 3) but before the
formation of osteoid. Adjacent sections were stained for ALP in
order to help localize the suture (Fig. 4A–C). Immunohistochem-
Figure 3. Alkaline-phosphatase (ALP) staining in the presumptive suture. Transverse sections through the E12.5 wild-type suture showed
a gap in ALP activity between the frontal and parietal bones (A). The width of the gap was reduced in the Gdf6+/2, with an increase in ALP activity
within the suture (B). In the Gdf62/2, there is a continuous line of ALP activity through the region, with a reduction in ALP activity in the parietal
portion of the fused bone (C). Similar changes in ALP staining were observed in the E13.5 and E14.5 rostral (G–I, M–O) and caudal (J–L, P–R) coronal
sutures and through in situ hybridization for Runx2 (D–F).
doi:10.1371/journal.pone.0036789.g003
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overall changes in the number of proliferating cells in heterozy-
gous or homozygous mutants as compared to wild-type, nor when
the suture mesenchyme, frontal bone, and parietal bone were
analyzed separately (Fig. 4D,E). Proliferation assays at E13.5 also
failed to detect significant differences across genotypes (Fig. S1)
although some trends toward altered proliferation rates in mutant
mice were suggested; although not significant statistically, these
trends may be secondary to the increased rate of differentiation in
the mutant sutures and thus, to changes in the pool of pre-
osteogenic proliferating cells.
To assay apoptosis, we used cleaved-caspase 3 immunohisto-
chemistry. Few to no apoptotic cells were detectable in the suture
mesenchyme or bone front in pre-ossified calvaria (Fig. S1),
consistent with previous reports that there are very few apoptotic
cells in fetal mouse calvaria prior to E16.5 [14] and likewise, no
significant difference between genotypes was found.
Gdf6 is Expressed in the Frontal Bone Primordia
The neural crest/paraxial mesoderm tissue boundary that
determines the future site of the coronal suture is formed by
E10.5 [13]. In order to pinpoint the pattern of Gdf6 expression
during cranial development and specifically in relation to
coronal suture formation, we performed in situ hybridization
on embryos at E9.5–E14.5. Gdf6 mRNA was first detected in
the developing cranial region in a triangular-shaped area just
anterior to the eye at E10.5 (Fig. 5A–C, arrow). This
corresponded closely with the neural crest-derived frontal bone
rudiment, as labeled in Wnt1-Cre; R26R embryos (Fig. 5D,
arrow). Gdf6 was expressed in the frontal bone rudiment at
E11.5 (Fig. 5H–J), as the rudiment begins to grow and expand.
Transverse sections through the E10.5 frontal rudiment
(depicted in Fig. 5E, dotted line) reveal that the site of
expression anterior to the eye was localized to several layers of
mesenchyme underlying the surface ectoderm (Fig. 5F,G). At
E12.5, Gdf6 continued to be exclusively expressed in the frontal
bone rudiment (Fig. 5K–M, arrow), with no evidence of
expression in the suture mesenchyme or parietal bone rudiment.
By E14.5, when fusion of the ossification centers was first visible
by alizarin red staining, Gdf6 is no longer expressed in the
suture region (Fig. S2).
Although no functional Gdf6 protein can be made from the
Gdf6 knockout allele, the mutant Gdf6 transcript can be detected
by our in situ RNA probe, which targets the 39 UTR of Gdf6. In situ
hybridization revealed that Gdf6 transcripts were still present in
Gdf62/2 embryos (Fig. 5C,J,M). Interestingly, the Gdf6 transcript
was more highly expressed in Gdf62/2 embryos than in either
wild-type or Gdf6+/2, with staining in Gdf6+/2 at intermediate
levels (Fig. 5A–C, H–J). Increased staining was also observed for
Gdf6 in the branchial arches of Gdf62/2 embryos (Fig. 5, A–C,
H–J asterix). These observations suggest that Gdf6 expression may
be self-regulated in these structures by a negative feedback loop. In
cross-section, Gdf6 expression was also observed in the orbital bone
rudiment (Fig. 5L) of wild-type, Gdf6+/2, and Gdf62/2 embryos
(not shown). Gdf6 is also normally expressed in the dorsal retina
where it functions in promoting eye development [15,16].
However, Gdf6 transcript was observed in the dorsal retina wild-
type and Gdf6+/2 embryos (Fig. 5K,L), but was lost in Gdf62/2
embryos (Fig. 5M), suggesting that in the retina Gdf6 autoregulates
through a positive feedback loop, in contrast to the negative
autoregulation in frontal bone and branchial arches.
Discussion
Here we present data indicating that Gdf6 is genetically required
for osteogenic differentiation in the developing coronal suture
during its formation. Gdf6 is absolutely required for formation of
the suture, as in Gdf62/2 embryos there is an initial failure to
establish a region of delayed differentiation between the frontal
and parietal condensations. We observed that Gdf6 mRNA is
strongly downregulated in wild-type calvaria by E14.5. It remains
unknown if Gdf6 plays roles at later stages to maintain patency of
Figure 4. Analysis of cell proliferation in the E12.5 coronal suture. Adjacent sections stained for ALP activity, highlighting the location of the
frontal and parietal bones (A–C dotted lines), and immunohistochemistry for phospho-histone H3 (A’–C’). Examples of positive cells are marked with
arrows. (D) Quantification of the mean number of proliferating cells counted in the combined frontal/suture/parietal region. (E) Quantification of the
mean number of proliferating cells counted in each region separately (the frontal bone, parietal bone, and suture mesenchyme) (x-axis). Since the
suture mesenchyme cannot be distinguished from the parietal in Gdf62/2 embryos at this time, only data for the frontal rudiment is shown for this
genoytpe. N=3 embryos for each genotype with 5 sections per embryo quantified. Differences the number of proliferating cells per suture region
were analyzed using a t-test.
doi:10.1371/journal.pone.0036789.g004
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a report that Gdf6 expression is detectable in calvarial sutures by
E16.5 [9]. The question of whether Gdf6 plays a role in suture
maintenance will require examination of Gdf6 protein stability
and localization, and/or conditional deletion of Gdf6 at later
stages.
Gdf6 Represses Osteogenic Differentiation but not
Boundary Formation in the Coronal Suture
We found no evidence for disruption in the frontal/parietal cell
boundary in Gdf62/2 mice. This is in contrast to the mechanism
of suture fusion in the Twist+/2, and Epha42/2 mice where,
before E14.5, osteogenic cells from the frontal bone abnormally
cross into the suture mesenchyme [5]. In Twist+/2 mice, ALP
activity in the frontal/parietal rudiments is normal in appearance
up to at least day E13.5 [5]. In contrast, ALP activity
abnormalities are detectable by E12.5 in Gdf62/2 embryos,
before ephrin ligands are expressed in the frontal/parietal region
[5]. Therefore Gdf6 is required for a mechanism of suture
formation that is distinct from that controlled by the Twist/Ephrin
pathway. Twist also regulates osteogenic condensation via in-
teraction with Msx2 [17]. Our data does not exclude Gdf6/Twist
interactions during osteogenic differentiation, although a combined
reduction of Twist and Msx2 levels was shown to primarily affect
differentiation of the frontal, but not the parietal bone, suggesting
this is possible [17].
Effects of Gdf6 Signaling in the Developing Calvarium
Somewhat surprisingly, Gdf6 mRNA was not detected in the
suture mesenchyme itself but in the frontal bone primordia.
This is in contrast to the sites of wrist and ankle joint fusion in
Gdf62/2 embryos, where Gdf6 is clearly expressed in the
developing joint interzones [9]. However, several studies suggest
that the action of GDFs in limb joint development is not
explained by direct autocrine suppression of chondrogenesis; for
example, both the direct application of GDF5 protein to
developing limb cartilage and transgenic Gdf5 overexpression
are pro-chondrogenic [8,18], although in limb joints the pro-
chondrogenic effects of GDFs are probably inhibited by Noggin
[19]. Gdf5/6/7 form a closely related subfamily of BMPs,
sharing .80% identity in their mature C-terminal signaling
domains [10]. The strong similarity of Gdf5 and Gdf6 suggest
they share similar signaling properties. Genetic evidence from
analysis of Gdf5/Gdf6 compound mutant mice supports the idea
that they have similar, partly redundant roles in skeletal
development that are determined largely by site of expression
rather than distinct signaling mechanisms [20]. A unifying
theme of both limb joints and the frontal bone is that both are
important paracrine signaling centers for adjacent targets (that
is, cartilage in the limb and the suture mesenchyme in the
Figure 5. Expression of Gdf6. In situ hybridization for Gdf6 at E10.5 (A–C, F,G), E11.5 (H–J), and E12.5 (K–M). Gdf6 was expressed in the frontal bone
primordia (arrow), which is labeled as neural crest-derived in the Wnt1-Cre; R26R transgenic embryos (D). Gdf6 transcript was expressed more strongly
in the Gdf62/2 embryo (C, J) than either the wild-type (A, H) or Gdf6+/2 embryo (B, I), in both the frontal bone rudiment (arrow) and branchial
arches (asterix). In transverse cross section through the eye and frontal bone primordia at E10.5 (dotted line, E), Gdf6 was expressed in several layers
of mesenchyme underlying the surface ectoderm (F, G). At E12.5, Gdf6 continues to be expressed in the frontal bone rudiment, in addition to the
dorsal retina (K–L) and orbital bone rudiment (L). Expression of Gdf6 in the dorsal retina seen in the wild-type and Gdf6+/2 (K,L) was absent in the
Gdf62/2 (M). dr, dorsal retina; e, eye; fr, frontal rudiment; or, orbital bone rudiment.
doi:10.1371/journal.pone.0036789.g005
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primordium enables it to serve as a paracrine signaling center to
affect cellular processes in the suture mesenchyme and the
parietal rudiment. It is not yet clear if this occurs via direct
signaling or through indirect effects transmitted by downstream
effectors.
Interestingly, the onset of ALP activity is delayed in the
parietal, but not frontal, primordia in Gdf62/2 embryos. Since
Gdf6 is expressed in the frontal but not parietal primordia, this
suggests Gdf6 signaling from the frontal primordium also acts in
a paracrine manner to influence maturation of the parietal. In
this view, Gdf6 actually stimulates osteogenic maturation of the
parietal rudiment, although it is not clear if this affect is direct
or indirect (for example, it could be a secondary effect mediated
by Gdf6 regulating a separate factor in the suture mesenchyme).
Therefore, data regarding Gdf6’s possible roles in skeletal
differentiation are important for interpretation of our results.
Several reports indicate that like Gdf5, Gdf6 can stimulate
chondrogenic differentiation in cell culture models [11].
Whether Gdf6 is pro- or anti-osteogenic is less clear. Some
studies indicate that in vitro, Gdf6 can have pro-osteogenic
effects on osteoblastic cells in similar manner to Gdf5, albeit its
ability to induce osteoblast markers is much less than that of the
‘‘canonical’’ osteogenic BMPs such as BMP2 or BMP7 [21].
However, Gdf6 can inhibit ALP expression and mineralization
in bone marrow-derived mesenchymal stem cells [22]. In vitro
experiments must be interpreted with caution, due to potential
differences in expression of BMP receptors and/or inhibitors
across cell lines. In general, in vitro studies indicate that Gdf6
seems consistently capable of promoting differentiation of
chondrogenic cells but relatively poor, or inhibitory, at pro-
moting osteogenesis.
However, injection of GDF5 into perinatal mouse calvaria in
vivo led to increased bone formation [23]. While this suggest GDFs
can have stimulatory effects on calvarial osteogenic differentiation,
the different timing and context of Gdf5 application may not lead
to the same effects as Gdf6 in the prenatal calvaria and Gdf6 may
have distinct signaling effects compared to Gdf5, despite similar
receptor usage [24]. Other studies indicate that the effects of Gdf6
on ALP induction are context dependent [25]. This effect might
be mediated by receptor subunit combinations, interactions with
inhibitors such as Noggin, or even heterodimerization with other
BMP family members. Noggin is expressed in layers surrounding
the developing frontal and parietal bones and can bind Gdf6 and
inhibit its signaling ability [26]. Noggin can repress BMP signaling
in the coronal suture [27], so it likely inhibits Gdf6-mediated
signaling. However, Noggin is not required for suture formation,
as Noggin2/2 embryos do form coronal sutures (not shown).
Therefore, Noggin is probably dispensable for the function of
Gdf6 in suppressing suture differentiation. However, our data
would not exclude the possibility that the reduction of ALP activity
in the Gdf62/2 E12.5 parietal bone could be caused by increased
Noggin activity, secondary to a reduction of Gdf6 that normally
suppresses Noggin. Xenopus GDF6 can heterodimerize with other
BMPs, such as BMP2, in vivo [26,28] and other BMP heterodimers
can have distinct and potent effects as compared to homodimers
[29]. Therefore it is possible that Gdf6/BMP heterodimers have
unique signaling properties.
Alternatively, it is possible that the relative temporal de-
velopment of the frontal and parietal rudiments is critical, and that
the relative delay of the parietal ossification sequence leads
indirectly to failure of suture establishment. However, the onset of
Runx2 transcription is not delayed in Gdf62/2 embryos,
suggesting Gdf6 is not required for temporal control of Runx2
mRNA in calvarial rudiments. We postulate that the suture
mesenchyme and the parietal rudiment may be differentially
sensitive to Gdf6 signaling.
Gdf6 Autoregulation and Interaction with other BMPs
We observed that Gdf6 transcription is increased in frontal bone,
but reduced in eyes, of Gdf62/2 embryos. This suggests
differential, tissue-specific autoregulation of Gdf6. Interestingly,
Gdf5 represses its own transcription in limb joints [8]. We propose
that Gdf6 autoregulates itself in the frontal bone and that Gdf6/
BMP signaling levels are fine-tuned during normal coronal suture
development to coordinate proper differentiation and morpho-
genesis. Interestingly, Bmp4 and Gdf6 are coexpressed in both the
dorsal retina and the frontal bone primordia [16]. Mutations in
Bmp4 and Gdf6 independently disrupt eye development [15,30,31].
Although Gdf6 is expressed in the frontal bone rudiment, there is
no evidence for a frontal bone defect in Gdf62/2. This is likely
due to compensation by Bmp4. Bmp4+/2; Gdf62/2 mice at
E18.5 do in fact have a frontal bone defect, with the persistence of
large fontanelles that is not observed in either single heterozygotes
(data not shown; manuscript in preparation). We speculate that
these two BMP ligands cooperate to regulate suture and/or
calvarial development.
Conclusions
In summary, we found that Gdf6 is required to control an early
stage of repressed osteogenic differentiation in the coronal suture.
Not only does this suggest potential new mechanisms for this BMP
family member in regulating bone growth, it nominates GDF6 as
a candidate gene harboring mutations in individuals with coronal
craniosynostosis. GDF6 mutations in humans have been associated
with eye and postcranial skeletal abnormalities although these
effects are characterized by incomplete penetrance and phenotypic
heterogeneity [15,32]. Interestingly, genomic lesions close to the
GDF6 genomic region are associated with Nablus Mask-Like
Facial Syndrome [33,34,35] which is a complex multigene
deletion syndrome characterized by loss of a critical region just
proximal to GDF6. In one of only two known patients where the
genomic deletion included GDF6, coronal craniosynostosis was
observed [33,34]. We propose that some individuals having
coronal craniosynostosis with unknown etiology may harbor
mutations in GDF6.
Materials and Methods
Mice, Crosses and Genotyping
The Gdf62/2 mouse [9] was a gift from Dr. David Kingsley
and was backcrossed onto a C57BL/6J background for more than
10 generations. Since the loss of Gdf6 is perinatal lethal on this
background (not shown), all time points were collected prenatally.
For fate mapping experiments, Gdf6+/2 mice were crossed to
R26R+/2 [36] to produce Gdf6+/2; R26R+/2 (double hetero-
zygotes), which were then crossed to Wnt1Cre+/2 [37]; Gdf6+/2
mice. Embryonic age was determined through detection of the
vaginal plug, with noon of that day observed as E0.5. DNA
samples for genotyping were isolated using tail snips from
postnatal mice and yolk sacs from embryos, and processed as
previously described [38]. The Gdf6 [9], R26R [36], and Wnt1-Cre
[39] lines were genotyped by PCR analysis as previously
described. The use of animals in this study was approved by the
Vanderbilt University Institutional Animal Care and Use Com-
mittee as part of animal use protocol M/09/293, approved on 1/
25/10 and 1/25/11.
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Mid-gestation mice from E14.5 to E18.5 were collected, organs
removed and skinned. Each specimen was placed in a separate
50 ml conical tube and then soaked in 95% ethanol for 1 day.
Specimens were agitated constantly on a shaker. Preps were then
stained in alcian blue solution [20% glacial acetic acid, 0.015%
alcian blue in 95% ethanol] for 14 days, destained in 95% ethanol
for 1 day, then transferred into 1% KOH until cleared. Once
cleared, the skeletal preps were placed in alizarin red staining
solution [0.00125% alizarin red in 1% KOH] for 1 day. Skeletal
preps were then transferred into graded changes of increasing
glycerol for storage (15%, 30%, 50%, 70%, 90% glycerol made in
16PBS, 100% glycerol).
Whole Mount and Slide in situ Hybridization
The Gdf6 RNA probe was generated by cloning a PCR
fragment using the primers 59- AAGCATGGAAGGAGGAT-
GAAAGGG- 39 and 59- CGACCTCCAGTAACTT-
TAGTGTTGTCA –39, targeting the Gdf6 39 untranslated region,
into the pGEM-Teasy vector (Promega). The Runx2 RNA probe
was made using the primers and protocol described previously
[40]. Hybridization was performed over night at 63uC, with
embryos incubated in 200 ng/ml (whole-mount) or 30 ng of probe
per slide (sections). For sectioning, embryos were equilibrated in
50% sucrose and then embedded in Tissue-Tek O.C.T.
compound (Sakura Finetek). Frozen sections were collected at
18 um. For each time-point, embryos were from the same litter
and stained for an equal length of time.
Histology
Embryos were dissected in 16PBS and fixed for 60 min at 4u in
10% neutral buffer formalin (Sigma), decapitated, bisected
sagittally, the skin removed, and fixed for another 15 min.
Embryos were prepared for X-Gal staining as previously described
[38]. Whole-mount specimens were further stained with alizarin
red overnight. Sectioned specimens were dehydrated through
ethanol series and embedded in paraffin. 10 mM sections were
collected and counterstained with nuclear fast red (Vector
Laboratories).
For staining for ALP activity, frozen sections were collected at
18 um and stored at –80uC until ready for staining. Slides were
brought to room temperature, then washed in acetone, TBST
[Tris-buffered saline pH 8.0, 1% Tween-20], and NTMT [0.1 M
NaCl, 0.1 M Tris-HCl pH 9.5, 50 mM MgCl2, 0.1% Tween-20]
at 4uC, stained with nitro-blue tetrazolium chloride (NBT) and
bromo-4-chloro-39-indolyphosphate p-toluidine (BCIP) at room
temperature, then counterstained with nuclear fast red.
Immunohistochemistry for Phospho-Histone-H3 (Ser10) and
Cleaved Caspase-3 (Asp175) was carried out on cryosections.
Slides were fixed in neutral buffer formalin, treated with 0.3%
H2O2 to quench endogenous peroxidase activity, and blocked with
5% normal goat serum in PBS. Diluted primary antibody
(Phospho-Histone-H3 1:200, Cleaved Caspase-3 1:12,800) was
applied overnight at 4uC. Sections were developed using
a biotinylated rabbit secondary antibody with ABC solution
(Vector Laboratories) and DAB.
Supporting Information
Figure S1 Analysis of cell proliferation and apoptosis in
the coronal suture. Adjacent sections stained for ALP activity,
highlighting the location of the frontal and parietal bones (A–F
dotted lines), and antibodies for phospho-histone H3 (A’–C’) or
cleaved caspase-3 (D’–F’). Positive cells are marked with arrows.
(G) Quantification of the mean number of proliferating cells (y-
axis) counted in the suture region (x-axis). (H) Quantification of the
mean number of proliferating cells (y-axis) counted in each region
of the suture; the frontal bone, parietal bone, and suture
mesenchyme (x-axis). The mean number of proliferating cells in
each region of the suture was not counted for Gdf62/2 embryos
since there is no suture mesenchyme and the border between the
frontal and parietal bones cannot be distinguished. N=3 embryos
for each genotype and antibody treatment with 5 sections per
embryo quantified. Differences the number of proliferating cells
per suture region were analyzed using a t-test.
(TIF)
Figure S2 Gdf6 expression at E14.5. Gdf6 expression was
downregulated in the frontal bone by E14.5 in wild-type (B),
Gdf6+/2 (D), and Gdf62/2 embryos (F). Adjacent sections were
stained for ALP to highlight the locations of the frontal and
parietal bones (E–G, dotted lines). Previously reported Gdf6
expression in the middle ear bone joints was clearly visible in
sections from the same series, acting as a positive control (G,H).
(TIF)
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